IRIS
MAZZEO, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.328
NA - Nord America 12.663
AS - Asia 7.908
SA - Sud America 2.681
Continente sconosciuto - Info sul continente non disponibili 605
AF - Africa 242
OC - Oceania 13
Totale 37.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.333
RU - Federazione Russa 6.530
SG - Singapore 3.660
BR - Brasile 2.268
CN - Cina 2.050
IE - Irlanda 1.706
SE - Svezia 1.167
IT - Italia 1.040
HK - Hong Kong 785
DE - Germania 713
FI - Finlandia 480
FR - Francia 470
VN - Vietnam 438
UA - Ucraina 406
PL - Polonia 287
GB - Regno Unito 243
IN - India 219
BD - Bangladesh 161
AR - Argentina 156
CA - Canada 124
MX - Messico 98
TR - Turchia 82
EC - Ecuador 70
ZA - Sudafrica 67
ID - Indonesia 66
IQ - Iraq 65
NL - Olanda 56
MA - Marocco 51
CO - Colombia 48
UZ - Uzbekistan 47
PK - Pakistan 46
BE - Belgio 45
JP - Giappone 44
AT - Austria 40
ES - Italia 38
VE - Venezuela 37
CL - Cile 34
CI - Costa d'Avorio 29
PY - Paraguay 25
KE - Kenya 24
PE - Perù 24
PH - Filippine 21
AZ - Azerbaigian 20
SA - Arabia Saudita 19
TN - Tunisia 19
IL - Israele 18
LT - Lituania 18
NP - Nepal 18
AE - Emirati Arabi Uniti 15
JM - Giamaica 15
CZ - Repubblica Ceca 14
EU - Europa 14
JO - Giordania 14
KZ - Kazakistan 14
AL - Albania 13
CR - Costa Rica 13
HN - Honduras 13
MY - Malesia 13
DZ - Algeria 12
DO - Repubblica Dominicana 11
TH - Thailandia 11
GT - Guatemala 10
KR - Corea 10
NI - Nicaragua 10
RO - Romania 10
AU - Australia 9
BO - Bolivia 9
EG - Egitto 9
KG - Kirghizistan 9
LB - Libano 9
UY - Uruguay 9
PR - Porto Rico 8
RS - Serbia 8
CH - Svizzera 7
IR - Iran 7
PS - Palestinian Territory 7
PA - Panama 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
GA - Gabon 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
OM - Oman 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BH - Bahrain 4
ET - Etiopia 4
KW - Kuwait 4
AO - Angola 3
BS - Bahamas 3
BW - Botswana 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
DM - Dominica 2
Totale 36.803
Salva come PNG Salva come JPEG
Città #
Moscow 2.144
Ashburn 1.835
Dublin 1.700
Singapore 1.560
Dallas 1.374
Chandler 1.110
Jacksonville 859
Hong Kong 781
Nyköping 752
Beijing 702
San Jose 500
Council Bluffs 470
The Dalles 371
Messina 345
Princeton 299
Munich 292
Warsaw 279
Lauterbourg 277
Medford 270
Los Angeles 268
Cambridge 233
Des Moines 219
Ann Arbor 181
Dearborn 175
Ho Chi Minh City 158
São Paulo 158
New York 154
Buffalo 149
Helsinki 149
Boardman 101
Tianjin 98
Santa Clara 83
Wilmington 78
Guangzhou 75
Turku 75
Orem 73
Hanoi 71
Rio de Janeiro 71
Redondo Beach 67
San Mateo 67
Jinan 65
Belo Horizonte 61
Shenyang 60
Bremen 52
Houston 49
Pune 47
Woodbridge 47
Brasília 45
Tashkent 44
Atlanta 43
Hyderabad 43
Chennai 42
Frankfurt am Main 42
Lancaster 41
Brooklyn 39
Shanghai 39
Rome 37
Curitiba 36
Nanjing 36
San Francisco 36
Tokyo 36
Seattle 35
Chicago 33
Montreal 33
Shenzhen 33
Columbus 32
Ningbo 32
Nuremberg 32
Porto Alegre 32
Hebei 31
Johannesburg 31
London 31
Milan 31
Brussels 30
Hangzhou 30
Zhengzhou 30
Abidjan 29
Phoenix 29
Mexico City 28
Baghdad 26
Denver 26
Guayaquil 26
Mumbai 26
Salvador 26
Boston 25
Dhaka 25
Haikou 25
Lappeenranta 25
Quito 25
Amsterdam 24
Toronto 24
Campinas 23
Catania 23
Istanbul 23
Nairobi 23
Palermo 23
Jakarta 22
Manchester 22
Taizhou 22
Vienna 22
Totale 20.631
Salva come PNG Salva come JPEG
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 684
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 369
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 342
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 336
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 332
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 288
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 277
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 257
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 256
Clinical and pathological features of focal myositis 251
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 251
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 248
A Nouvel serum MicroRNA signature to screen ATTR 233
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 231
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 225
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 216
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 213
Dolori muscolari, deficit di forza e/o disturbi sensitivi 200
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 195
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 194
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 191
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 184
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 184
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 180
ANT1 is reduced in sporadic inclusion body myositis. 179
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 178
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 175
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 172
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 172
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 171
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 171
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 170
A novel Cx32 mutation with unusual phenotype. 170
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 170
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 170
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 168
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 168
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 164
Coinvolgimento Cardiaco in Pazienti con Polineuropatia Amiloidotica Familiare: Dimostrazione Precoce con Cardio-Rm 163
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 162
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 161
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 160
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 160
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 159
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 158
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 157
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 157
Cardiac involvement in transthyretin familial amyloid polyneuropathy - comparison between 99mTc-DPD SPECT and magnetic resonance imaging 156
Dolori muscolari, deficit di forza e/o disturbi sensitivi 156
Acquired idiopathic generalized anhidrosis: a case report 155
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 155
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 154
Acquired idiopathic generalized anhidrosis: a case report 152
A novel Cx32 mutation with unusual phenotype 152
A novel CX32 mutation with unusual phenotype 151
Correlation between semiquantitative analysis of 99mTc-DPD scintigraphy and clinical scores in patients with familial amyloidotic polyneuropathy 151
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 151
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 150
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 149
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 149
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 148
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 148
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 146
Nerve conduction velocity in CMT1A: what else can we tell? 146
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 145
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 145
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 144
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 144
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 143
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG. 143
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG 142
Atrial function in cardiac amyloidosis: a 2d-strain echocardiography and cardiac MRI study 142
Amyloid myopathy presenting with rhabdomyolysis 141
Cardiac Involvement in Patients with Family Amyloid Polyneuropathy: Early Demostration with Cardiac Magnetic Resonance 139
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 138
Quantitative comparison between amyloid deposition detected by 99mTC-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis 137
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 136
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 136
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 136
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 136
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 135
Behaviour of Vinculin and Talin in Perineurial Cells in Healthy Subjects and in Subjects Affected by Diabetic Neuropathy. 135
Amyloid myopathy presenting with rhabdomyolysis. 134
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 133
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 133
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 133
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 132
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 132
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 131
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 131
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 131
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 131
Acquired idiopathic generalized anhidrosis: a case report. 129
Considerable post-partum worsening in a patient with CMT2E 129
Dp116, talin, vinculin and vimentin immunoreactivities following nerve transection 128
A novel CX32 mutation with unusual phenotype 128
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 127
Totale 17.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.650 0 188 33 85 97 15 135 86 41 95 204 671
2022/20234.505 387 389 219 308 317 415 46 250 2.017 22 102 33
2023/20241.090 79 184 92 73 94 251 26 69 5 72 13 132
2024/20256.750 130 61 95 361 284 315 307 1.288 1.529 336 827 1.217
2025/202617.020 802 1.259 1.504 1.320 1.374 3.566 1.956 1.945 1.928 724 303 339
2026/20271.723 750 973 0 0 0 0 0 0 0 0 0 0
Totale 37.440